Product Description
The global electrical stimulation market for spinal fusion was valued at over $610 million in 2024. This is expected to increase at a CAGR of 4.4% over the forecast period, reaching over $820 million by 2031.
The full report suite on the global market for electrical stimulation in spinal fusion includes segments for cervical and lumbar electrical stimulation devices.
This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL SPINAL ELECTRICAL STIMULATION MARKET TRENDS
A notable ongoing trend is the increased use of electrical stimulation in outpatient settings, as minimally invasive spinal fusion procedures become more common. Additionally, there is growing interest in next-generation stimulators with wireless control and patient-specific programming capabilities.
GLOBAL SPINAL ELECTRICAL STIMULATION MARKET SHARE INSIGHTS
- Orthofix held the leading position in the global electrical stimulation market in 2024, commanding over half of the total market share. The company maintained strong leadership across all regions, with particularly dominant shares in North America and Western Europe. Orthofix’s consistent performance globally reflects its established brand, broad clinical adoption and product reliability in both cervical and lumbar stimulation segments.
- ZimVie/(Highridge Medical) ranked second in the global market, capturing over one-fifth of total sales. The company demonstrated a strong regional presence, especially in Western Europe and the Rest of the World. ZimVie’s success is attributed to its portfolio of stimulation technologies focused on spinal fusion support, as well as its growing penetration in emerging markets.
- Enovis was the third-largest competitor in 2024, holding a significant share across all regions. The company performed well in North America and maintained competitive positioning in the Rest of the World. Enovis’ continued investment in electrical stimulation technologies and its diversified orthopedic product base have helped reinforce its global market share.
MARKET SEGMENTATION SUMMARY
- Electrical Stimulation Market – Further Segmented Into:
- Anatomy: Cervical and Lumbar.
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
